OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 71 filers reported holding OYSTER PT PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 0 | – | 0.00% | – |
| Q2 2023 | $0 | – | 0 | – | 0.00% | – |
| Q1 2023 | $0 | – | 0 | – | 0.00% | – |
| Q4 2022 | $0 | – | 0 | – | 0.00% | – |
| Q3 2022 | $0 | – | 0 | – | 0.00% | – |
| Q2 2022 | $0 | – | 0 | – | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2021 | $124,000 | +53.1% | 6,800 | 0.0% | 0.01% | +40.0% |
| Q3 2021 | $81,000 | -30.8% | 6,800 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $117,000 | -12.0% | 6,800 | -6.8% | 0.01% | -22.2% |
| Q1 2021 | $133,000 | -2.9% | 7,300 | 0.0% | 0.01% | -10.0% |
| Q4 2020 | $137,000 | -8.7% | 7,300 | +2.8% | 0.01% | -23.1% |
| Q3 2020 | $150,000 | – | 7,100 | – | 0.01% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $52,105,000 | 21.78% |
| Vida Ventures Advisors, LLC | 778,468 | $14,651,000 | 3.01% |
| NEA Management Company, LLC | 5,925,287 | $111,514,000 | 2.94% |
| RTW INVESTMENTS, LP | 1,925,594 | $36,240,000 | 0.61% |
| COOPER CREEK PARTNERS MANAGEMENT LLC | 89,200 | $1,679,000 | 0.42% |
| EMERALD ADVISERS, LLC | 291,936 | $5,494,000 | 0.18% |
| OAK RIDGE INVESTMENTS LLC | 71,865 | $1,352,000 | 0.12% |
| Virtus ETF Advisers LLC | 14,729 | $277,000 | 0.12% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $19,566,000 | 0.10% |
| AlphaCentric Advisors LLC | 12,000 | $226,000 | 0.09% |